Medicines labeled for the same conditions
Alternatives to brivaracetam
18 other medicines are given the same way (oral) and in the same FDA class as brivaracetam or labeled mainly for the same use (seizures and epilepsy); the others include 8 anti-epileptic agents, 2 mood stabilizers and 1 benzodiazepine (FDA labels read October 8, 2026).
Which medicines are labeled for the same conditions as brivaracetam?
Seizures and epilepsy lists all 27 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Brivaracetam | this medicine | 14 labelers | $0.259 per tablet 100 mg tablet | No | No current entry |
| Topiramate | Seizures and epilepsy | 47 labelers | $0.0567 per tablet 100 mg tablet | No | No current entry |
| Lamotriginemood stabilizer | Seizures and epilepsy | 50 labelers | $0.0268 per tablet 25 mg tablet | Yes | A presentation being discontinued |
| Levetiracetam | Seizures and epilepsy | 63 labelers | $0.0736 per tablet 500 mg tablet | No | No current entry |
| Phenobarbital | Seizures and epilepsy | none listed | $0.213 per tablet 100 mg tablet | No | A presentation being discontinued |
| Clonazepambenzodiazepine | Seizures and epilepsy | 31 labelers | $0.0244 per tablet 1 mg tablet | Yes | In shortage |
| Lacosamide | Seizures and epilepsy | 43 labelers | $0.174 per tablet 100 mg tablet | No | No current entry |
| Oxcarbazepineanti-epileptic agent | Seizures and epilepsy | 43 labelers | $0.167 per tablet 300 mg tablet | No | No current entry |
| Zonisamideanti-epileptic agent | Seizures and epilepsy | 20 labelers | $0.106 per capsule 100 mg capsule | No | No current entry |
| Valproic acidmood stabilizer | Seizures and epilepsy | 19 labelers | $0.243 per capsule 250 mg capsule | Yes | Listed; available |
| Phenytoinanti-epileptic agent | Seizures and epilepsy | 23 labelers | $0.145 per capsule 100 mg capsule | No | No current entry |
| Primidoneanti-epileptic agent | Seizures and epilepsy | 21 labelers | $0.0914 per tablet 50 mg tablet | No | No current entry |
| Eslicarbazepine | Seizures and epilepsy | 9 labelers | $1.68 per tablet 200 mg tablet | No | No current entry |
| Perampanelnoncompetitive ampa glutamate receptor antagonist | Seizures and epilepsy | 3 labelers | $14.43 per tablet 4 mg tablet | Yes | No current entry |
| Felbamateanti-epileptic agent | Seizures and epilepsy | 9 labelers | $1.00 per tablet 600 mg tablet | Yes | No current entry |
| Ethosuximideanti-epileptic agent | Seizures and epilepsy | 9 labelers | $0.243 per capsule 250 mg capsule | No | No current entry |
| Cenobamate | Seizures and epilepsy | none listed | $39.87 per tablet 100 mg tablet | No | No current entry |
| Tiagabineanti-epileptic agent | Seizures and epilepsy | 2 labelers | $2.62 per tablet 2 mg tablet | No | A presentation being discontinued |
| Methsuximideanti-epileptic agent | Seizures and epilepsy | 1 labeler | $4.40 per capsule 300 mg capsule | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Brivaracetam: the full record
- label, generics, price, shortages, recalls
- Brivaracetam vs topiramate
- two records side by side
- Levetiracetam vs brivaracetam
- two records side by side
- Brivaracetam vs clonazepam
- two records side by side